Page last updated: 2024-10-29

imipramine and Central Nervous System Diseases

imipramine has been researched along with Central Nervous System Diseases in 8 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.

Research Excerpts

ExcerptRelevanceReference
"Acute anticholinergic delirium has been reported to occur following ingestion of antidepressants, neuroleptics and antiparkinsonian drugs in toxic and therapeutic doses."1.27Chronic central anticholinergic toxicity in manic depressive illness mimicking dementia. ( Banno, V; Jones, BD; Moreau, A, 1986)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19907 (87.50)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valli, M1
Betti, AH1
Danuello, A1
Pivatto, M1
Centurião, F1
Antonio, CB1
Rates, SM1
Bolzani, Vda S1
Strauss, W1
Small, JG1
Small, IF1
Moreau, A1
Jones, BD1
Banno, V1
Ashcroft, GW1
Crawford, TB1
Eccleston, D1
Sharman, DF1
MacDougall, EJ1
Stanton, JB1
Binns, JK1
Nelson, SR1
Walaszek, EJ1
Rivera de Reyes, AM1
Gaytán-Becerril, A1
Rubio-Alvarez, V1
Allert, ML1

Reviews

1 review available for imipramine and Central Nervous System Diseases

ArticleYear
Pharmacology of the central nervous system.
    Progress in neurology and psychiatry, 1968, Volume: 23

    Topics: Abnormalities, Drug-Induced; Acetylcholine; Adrenocorticotropic Hormone; Amphetamine; Anger; Angiote

1968

Other Studies

7 other studies available for imipramine and Central Nervous System Diseases

ArticleYear
Pyridinic analog of the natural product (-)-spectaline as potential adjuvant for the treatment of central nervous system disorders.
    Bioorganic & medicinal chemistry letters, 2015, Volume: 25, Issue:10

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Central Nervous System Diseases; Disease Models, A

2015
[On the problem of nocturnal enuresis and its therapy with Tofranil].
    Munchener medizinische Wochenschrift (1950), 1966, Sep-16, Volume: 108, Issue:37

    Topics: Adolescent; Central Nervous System Diseases; Child; Child, Preschool; Electroencephalography; Enures

1966
EEG spikes in non-epileptic psychiatric patients.
    Diseases of the nervous system, 1967, Volume: 28, Issue:8

    Topics: Adolescent; Adult; Aged; Amitriptyline; Antisocial Personality Disorder; Barbiturates; Brain; Brain

1967
Chronic central anticholinergic toxicity in manic depressive illness mimicking dementia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1986, Volume: 31, Issue:4

    Topics: Aged; Amitriptyline; Benztropine; Bipolar Disorder; Central Nervous System Diseases; Dementia; Diagn

1986
5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.
    Lancet (London, England), 1966, Nov-12, Volume: 2, Issue:7472

    Topics: Alcoholism; Bipolar Disorder; Central Nervous System Diseases; Humans; Hydroxyindoleacetic Acid; Imi

1966
[Poisoning by imipramine in a newborn infant].
    Gaceta medica de Mexico, 1973, Volume: 105, Issue:4

    Topics: Cardiovascular Diseases; Central Nervous System Diseases; Electrocardiography; Humans; Imipramine; I

1973
[nil nocere; side-effects, complications and dangers of psychopharmaceutical drug therapy].
    Munchener medizinische Wochenschrift (1950), 1965, Dec-03, Volume: 107, Issue:49

    Topics: Amitriptyline; Antidepressive Agents; Butyrophenones; Central Nervous System Diseases; Imipramine; M

1965